Description of Release Process of Doxorubicin from Modified Carbon Nanotubes

Int J Mol Sci. 2021 Nov 5;22(21):12003. doi: 10.3390/ijms222112003.

Abstract

The article discusses the release process of doxorubicin hydrochloride (DOX) from multi-wall carbon nanotubes (MWCNTs). The studies described a probable mechanism of release and actions between the surface of functionalized MWCNTs and anticancer drugs. The surface of carbon nanotubes (CNTs) has been modified via treatment in nitric acid to optimize the adsorption and release process. The modification efficiency and physicochemical properties of the MWCNTs+DOX system were analyzed by using SEM, TEM, EDS, FTIR, Raman Spectroscopy and UV-Vis methods. Based on computer simulations at pH 7.4 and the experiment at pH 5.4, the kinetics and the mechanism of DOX release from MWNT were discussed. It has been experimentally observed that the acidic pH (5.4) is appropriate for the efficient release of the drug from CNTs. It was noted that under acidic pH conditions, which is typical for the tumour microenvironment almost 90% of the drug was released in a relatively short time. The kinetics models based on different mathematical functions were used to describe the release mechanism of drugs from MWCNTs. Our studies indicated that the best fit of experimental kinetic curves of release has been observed for the Power-law model and the fitted parameters suggest that the drug release mechanism of DOX from MWCNTs is controlled by Fickian diffusion. Molecular dynamics simulations, on the other hand, have shown that in a neutral pH solution, which is close to the blood pH, the release process does not occur keeping the aggregation level constant. The presented studies have shown that MWCNTs are promising carriers of anticancer drugs that, depending on the surface modification, can exhibit different adsorption mechanisms and release.

Keywords: doxorubicin; drug delivery; drug release mechanism; kinetics of release; modified carbon nanotubes.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics
  • Doxorubicin / chemistry*
  • Doxorubicin / pharmacokinetics
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Hydrogen-Ion Concentration
  • Kinetics
  • Molecular Dynamics Simulation
  • Nanotubes, Carbon / chemistry*
  • Spectrum Analysis, Raman / methods

Substances

  • Antineoplastic Agents
  • Nanotubes, Carbon
  • Doxorubicin